14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:INFI
Delisted

Infinity Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 28, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0160 $0.0160 Thursday, 28th Dec 2023 INFI stock ended at $0.0160. During the day the stock fluctuated 0% from a day low at $0.0160 to a day high of $0.0160.
90 days $0.0115 $0.0190
52 weeks $0.0111 $0.770

Historical Infinity Pharmaceuticals prices

Date Open High Low Close Volume
Nov 21, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 20, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 17, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 16, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 15, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 14, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 13, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 10, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 09, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 08, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 07, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 06, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 03, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 02, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Nov 01, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 31, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 30, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 27, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 26, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 25, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 24, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 23, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 20, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 19, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Oct 18, 2023 $0.0160 $0.0160 $0.0160 $0.0160 0
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT